Lynx1 Capital Management »

Tscan Therapeutics shares owned by Lynx1 Capital Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Lynx1 Capital Management from 13F filings

Historical chart of Lynx1 Capital Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Lynx1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Lynx1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $31M 5.2M 5.83
2023-09-30 $13M 5.2M 2.56
2023-06-30 $13M 5.2M 2.50